A review of pioglitazone HCL and glimepiride in the treatment of type 2 diabetes
Mozhgan Dorkhan, Anders FridDepartment of Clinical Sciences, Division of Diabetes and Endocrinology, Lund University, Malmö University Hospital, SwedenAbstract: Type 2 diabetes (T2D) is a progressive disorder with a consistent and steady increase in glycosylated hemoglobin (HbA1c) over time...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2007-11-01
|
| Series: | Vascular Health and Risk Management |
| Online Access: | https://www.dovepress.com/a-review-of-pioglitazone-hcl-and-glimepiride-in-the-treatment-of-type--peer-reviewed-article-VHRM |